Navigation Links
eInfochips collaborates with EchoNous Inc. to develop the recently FDA-cleared KOSMOS platform

eInfochips, a leading provider of product engineering services and enabler of digital transformation for enterprises globally, has collaborated with EchoNous Inc. to develop the cloud-based connected health KOSMOS platform that has been cleared by the FDA. It can measure systolic heart function, which has been clinically tested versus expert measurements, yielding improved results in precision and consistency.

KOSMOS’ handheld probe and proprietary clinical viewing tool (tablet) can move quickly and easily through busy hospital wards. Its hospital-grade materials can withstand frequent disinfection with harsh cleaning chemicals, making KOSMOS not only an excellent imager of the torso but also a time-efficient tool in overwhelmed emergency rooms and ICUs that are desperate to shrink the infection footprint quickly.

The KOSMOS platform includes an 8-ounce ultrasound-imaging tool with custom-designed ASIC, synchronized ECG and digital auscultation, and a proprietary tablet featuring the Qualcomm® SDA835 System-on-chip (SoC) built to withstand heavy use in clinical settings while protecting patient data.

The eInfochips team created a cloud platform to enable deep-learning algorithm development. The team also worked on software tools and applications that make the platform easy to use.

eInfochips also helped develop a scalable remote device management platform that enables rapid provisioning and management, including over-the-air firmware updates, of the devices in the field. In addition, the eInfochips team has contributed to the device firmware and implementation of the user interface.

Both applications leverage the Microsoft Azure cloud platform and its IoT services to provide edge-to-cloud solutions that empower customers such as EchoNous to seamlessly build, deploy and scale connected healthcare solutions.

“This marks an important milestone in our relationship with EchoNous Inc. Our experience with silicon, embedded and digital technologies, coupled with our cloud collaboration with Microsoft Azure and work with Qualcomm Technologies, helps ensure that we deliver solutions that get our customers to market faster,” said Parag Mehta, chief business development Officer, eInfochips.

eInfochips has extensive experience in developing FDA Class 2 and Class 3 medical devices for monitoring, diagnostics and imaging, wearable health and telemedicine. It provides HIPAA-compliant medical products engineering solutions and has the required process expertise in IEC 60601-1/2/6, IEC 62304, 510K and ISO 13485.

“eInfochips has been key in complementing our core competencies in ultrasound and AI with their expertise in cloud, embedded and mobile app development. We look forward to the continuation of this collaboration as we expand the clinical value of the KOSMOS platform," said Rama Pailoor, vice president of software and cloud engineering at EchoNous.

About EchoNous
EchoNous's vision since inception has been to create an unprecedented diagnostic tool in the handheld format that is low-cost and capable of delivering high clinical value through the meaningful application of artificial intelligence. They will continue to apply deep learning tools to clinical challenges in everyday healthcare.

About eInfochips
eInfochips, an Arrow Electronics company, is a leading provider of digital transformation and product engineering services. With over 500-plus products developed and 40 million deployments in 140 countries, eInfochips continues to fuel technological innovations in multiple verticals.

eInfochips accelerates time to market for its customers with its expertise in the areas of IoT, AI/ML, security, sensors, wireless, cloud, and power. With collaborations across the technology spectrum, eInfochips has developed reference platforms and industry-specific solutions to enable next-generation product development and transformation.

For more information contact Jaideep Chowdhary, at, or visit

Qualcomm is a trademark of Qualcomm Incorporated, registered in the United States and other countries.
Qualcomm SDA845 is a product of Qualcomm Technologies, Inc. and/or its subsidiaries.

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology news :

1. EconoFact Collaborates with Macmillan Learning to Enhance Digital Learning Materials for Economics Courses
2. Abcam Collaborates with Visikol to Develop New Tools for Improved Tissue Clearing and 3D Imaging
3. UTMB collaborates on program targeting potential bioterrorist pathogens Ebola and Marburg
4. Life Technologies Collaborates with Canadian Centre for DNA Barcoding on Species Biodiversity Study
5. Mainz University collaborates with 3 Chinese universities in research and teaching
6. Florida Hospital collaborates with VTT of Finland
7. Gritstone Oncology Adopts Genedata Biopharma Platform to Accelerate Development of TCR and Bispecific Antibody Therapeutics
8. Oxford Nanopore Technologies announces advanced development of LamPORE, for rapid, highly scalable, low-cost COVID-19 detection
9. InBios Obtains BARDA Funding to Develop Point-of-Care COVID-19 Test
10. Mount Sinai Researchers Collaborate with GenScript to Develop a COVID-19 Antibody to Treat Sick Patients
11. GTT Group’s Patent Equity Fund, Ideaship, Invests in Captis Biotechnology, Inc. to Develop Reliable and Inexpensive Diagnostic Platforms for Early Disease Detection
Post Your Comments:
(Date:6/5/2020)... (PRWEB) , ... June 04, 2020 , ... “Although we ... health and well-being of our attendees, staff, and the public. We remain committed ... and safe ways to collaborate virtually,” said Julie Sutcliffe, President of WMIS. ...
(Date:5/28/2020)... ... 2020 , ... CrucialTrak, a global designer and manufacturer of biometric access control ... to market and sell its complete line of biometric readers and access gates ... optimization solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales for the ...
(Date:5/26/2020)... , ... May 26, 2020 ... ... enterprise software solutions for biopharmaceutical R&D, today announced that Gritstone Oncology, Inc., ... receptor (TCR)-mimetic bispecific T cell engagers and TCR-based therapeutics, has implemented ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... , ... July 29, 2020 , ... ... announced the launch of its new tagline, “BUILDING FOR LIFE.” The adoption of ... and around the globe, requiring fast track capacity to provide patients with urgently ...
(Date:7/31/2020)... SOMERSET, N.J (PRWEB) , ... July 29, 2020 ... ... editing company, and Catalent, the leading global provider of advanced delivery technologies, development, ... products, today announced that they have entered into a strategic partnership whereby Catalent ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... today announced the release of its signature product called Beacon - a ... and other field medical professionals. , Beacon helps MSLs streamline communication ...
(Date:7/18/2020)... ... 2020 , ... “We are thrilled to deliver this new technology to the ... its kind on the market and we were pleased that the IFT jury recognized ... cultured ingredients, creating a natural way to extend the shelf life and improve the ...
Breaking Biology Technology: